ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 103 filers reported holding ANTARES PHARMA INC in Q2 2017. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $12,299,000 | +17.3% | 2,999,779 | +2.2% | 0.00% | +100.0% |
Q4 2021 | $10,481,000 | +1.1% | 2,935,962 | +3.1% | 0.00% | 0.0% |
Q3 2021 | $10,370,000 | -15.0% | 2,848,983 | +1.8% | 0.00% | -50.0% |
Q2 2021 | $12,205,000 | +11.9% | 2,799,516 | +5.5% | 0.00% | 0.0% |
Q1 2021 | $10,911,000 | +11.9% | 2,654,791 | +8.6% | 0.00% | 0.0% |
Q4 2020 | $9,749,000 | +48.6% | 2,443,539 | +0.5% | 0.00% | +100.0% |
Q3 2020 | $6,561,000 | +2.0% | 2,430,310 | +3.9% | 0.00% | 0.0% |
Q2 2020 | $6,430,000 | +18.7% | 2,338,263 | +1.9% | 0.00% | 0.0% |
Q1 2020 | $5,415,000 | -72.9% | 2,294,526 | -46.0% | 0.00% | -50.0% |
Q4 2019 | $19,958,000 | +191.1% | 4,246,402 | +107.1% | 0.00% | 0.0% |
Q3 2019 | $6,857,000 | +7.0% | 2,050,200 | +5.2% | 0.00% | 0.0% |
Q2 2019 | $6,410,000 | +21.9% | 1,948,338 | +12.3% | 0.00% | +100.0% |
Q1 2019 | $5,258,000 | -39.9% | 1,735,406 | -46.1% | 0.00% | 0.0% |
Q4 2018 | $8,756,000 | +80.8% | 3,219,444 | +123.3% | 0.00% | 0.0% |
Q3 2018 | $4,844,000 | +36.1% | 1,442,027 | +4.5% | 0.00% | 0.0% |
Q2 2018 | $3,560,000 | +24.6% | 1,379,873 | +6.2% | 0.00% | 0.0% |
Q1 2018 | $2,857,000 | +11.9% | 1,298,980 | +1.2% | 0.00% | 0.0% |
Q4 2017 | $2,554,000 | -39.8% | 1,283,758 | -2.0% | 0.00% | -50.0% |
Q3 2017 | $4,243,000 | +10.7% | 1,309,831 | +10.1% | 0.00% | 0.0% |
Q2 2017 | $3,832,000 | +40.8% | 1,190,138 | +24.2% | 0.00% | +100.0% |
Q1 2017 | $2,721,000 | +27.7% | 958,234 | +4.8% | 0.00% | 0.0% |
Q4 2016 | $2,130,000 | +55.1% | 914,605 | +11.9% | 0.00% | 0.0% |
Q3 2016 | $1,373,000 | +70.1% | 817,343 | +6.2% | 0.00% | – |
Q2 2016 | $807,000 | +0.6% | 769,440 | -16.6% | 0.00% | – |
Q1 2016 | $802,000 | -27.6% | 922,527 | +0.7% | 0.00% | -100.0% |
Q4 2015 | $1,108,000 | -28.0% | 916,528 | +1.2% | 0.00% | 0.0% |
Q3 2015 | $1,539,000 | -12.6% | 905,847 | +7.0% | 0.00% | 0.0% |
Q2 2015 | $1,760,000 | -11.5% | 846,340 | +15.3% | 0.00% | 0.0% |
Q1 2015 | $1,988,000 | +17.8% | 733,721 | +11.7% | 0.00% | 0.0% |
Q4 2014 | $1,688,000 | +42.2% | 656,812 | +1.2% | 0.00% | 0.0% |
Q3 2014 | $1,187,000 | -30.7% | 648,765 | +1.0% | 0.00% | 0.0% |
Q2 2014 | $1,714,000 | -22.9% | 642,220 | +1.1% | 0.00% | 0.0% |
Q1 2014 | $2,223,000 | -20.4% | 635,235 | +1.9% | 0.00% | -50.0% |
Q4 2013 | $2,793,000 | +35.4% | 623,439 | +22.7% | 0.00% | 0.0% |
Q3 2013 | $2,063,000 | +2.6% | 508,199 | +5.2% | 0.00% | 0.0% |
Q2 2013 | $2,011,000 | – | 483,298 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|